Treatment of Hypersensitivity Pneumonitis in Fibrotic HP with Severe or Progressive Disease

This protocol applies to patients with hypersensitivity pneumonitis who have developed a fibrotic phenotype accompanied by severe lung function impairment or evidence of progressive disease — a presentation that calls for a structured treatment approach.

In fibrotic hypersensitivity pneumonitis with severe or progressive lung involvement, immunosuppressive therapy may be considered as part of the clinical management strategy.

Management in this setting may involve corticosteroids, though their role in fibrotic HP warrants careful clinical evaluation. The complete structured regimen — including sequencing and further considerations for this presentation — is available via the full protocol.